Cinctive Capital Management LP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 246 filers reported holding HAEMONETICS CORP in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cinctive Capital Management LP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$12,486,377
+151.5%
139,388
+139.1%
0.62%
+272.3%
Q2 2023$4,963,832
-65.7%
58,302
-66.7%
0.17%
-65.6%
Q1 2023$14,491,594
+161.4%
175,125
+148.4%
0.48%
+77.9%
Q4 2022$5,544,039
-53.3%
70,490
-56.1%
0.27%
-45.5%
Q3 2022$11,884,000
+209.7%
160,526
+195.4%
0.50%
+164.4%
Q3 2021$3,837,000
+265.4%
54,351
+244.9%
0.19%
+283.7%
Q2 2021$1,050,000
-76.6%
15,759
-58.2%
0.05%
-86.6%
Q4 2020$4,481,000
+143.5%
37,733
+79.0%
0.36%
+126.7%
Q3 2020$1,840,00021,0840.16%
Other shareholders
HAEMONETICS CORP shareholders Q3 2021
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders